Clinical considerations for managing dermatology patients on systemic immunosuppressive or biologic therapy, or both, during the COVID-19 pandemic

Detalles Bibliográficos
Autores principales: Sanchez, Daniela P., Kirsner, Robert S., Lev-Tov, Hadar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the American Academy of Dermatology, Inc. 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198181/
https://www.ncbi.nlm.nih.gov/pubmed/32380214
http://dx.doi.org/10.1016/j.jaad.2020.04.143
_version_ 1783528948974485504
author Sanchez, Daniela P.
Kirsner, Robert S.
Lev-Tov, Hadar
author_facet Sanchez, Daniela P.
Kirsner, Robert S.
Lev-Tov, Hadar
author_sort Sanchez, Daniela P.
collection PubMed
description
format Online
Article
Text
id pubmed-7198181
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher by the American Academy of Dermatology, Inc.
record_format MEDLINE/PubMed
spelling pubmed-71981812020-05-05 Clinical considerations for managing dermatology patients on systemic immunosuppressive or biologic therapy, or both, during the COVID-19 pandemic Sanchez, Daniela P. Kirsner, Robert S. Lev-Tov, Hadar J Am Acad Dermatol Research Letter by the American Academy of Dermatology, Inc. 2020-07 2020-05-04 /pmc/articles/PMC7198181/ /pubmed/32380214 http://dx.doi.org/10.1016/j.jaad.2020.04.143 Text en © 2020 by the American Academy of Dermatology, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Research Letter
Sanchez, Daniela P.
Kirsner, Robert S.
Lev-Tov, Hadar
Clinical considerations for managing dermatology patients on systemic immunosuppressive or biologic therapy, or both, during the COVID-19 pandemic
title Clinical considerations for managing dermatology patients on systemic immunosuppressive or biologic therapy, or both, during the COVID-19 pandemic
title_full Clinical considerations for managing dermatology patients on systemic immunosuppressive or biologic therapy, or both, during the COVID-19 pandemic
title_fullStr Clinical considerations for managing dermatology patients on systemic immunosuppressive or biologic therapy, or both, during the COVID-19 pandemic
title_full_unstemmed Clinical considerations for managing dermatology patients on systemic immunosuppressive or biologic therapy, or both, during the COVID-19 pandemic
title_short Clinical considerations for managing dermatology patients on systemic immunosuppressive or biologic therapy, or both, during the COVID-19 pandemic
title_sort clinical considerations for managing dermatology patients on systemic immunosuppressive or biologic therapy, or both, during the covid-19 pandemic
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198181/
https://www.ncbi.nlm.nih.gov/pubmed/32380214
http://dx.doi.org/10.1016/j.jaad.2020.04.143
work_keys_str_mv AT sanchezdanielap clinicalconsiderationsformanagingdermatologypatientsonsystemicimmunosuppressiveorbiologictherapyorbothduringthecovid19pandemic
AT kirsnerroberts clinicalconsiderationsformanagingdermatologypatientsonsystemicimmunosuppressiveorbiologictherapyorbothduringthecovid19pandemic
AT levtovhadar clinicalconsiderationsformanagingdermatologypatientsonsystemicimmunosuppressiveorbiologictherapyorbothduringthecovid19pandemic

Ejemplares similares